
What smart money is saying about Pro Medicus
2 funds in our archive have pitched Pro Medicus — most recently Vision Capital Fund in March 2026.
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Fund coverage · 2 theses
- Vision Capital FundMarch 2026
Pro Medicus is a high-quality, recurring-revenue medical imaging SaaS business with strong switching costs, premium technology, and long-duration contracts.
Read the full thesis - Sands Capital Global GrowthJune 2025
Pro Medicus is a leading healthcare IT provider that specializes in cloud-native imaging software, demonstrating strong growth potential and high customer loyalty.
Read the full thesis
Read every full thesis on Pro Medicus
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→